A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration
Clinical trial NCT04640272 · COMPLETED
Trial details
- NCT number
- NCT04640272
- Sponsor
- Ribomic USA Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2021-11-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.